These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33740336)

  • 1. Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in patients with polycystic ovary syndrome.
    Altinkaya SO
    Arch Endocrinol Metab; 2021 Nov; 65(4):479-487. PubMed ID: 33740336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.
    Jędrzejuk D; Lwow F; Kuliczkowska-Płaksej J; Hirnle L; Trzmiel-Bira A; Lenarcik-Kabza A; Kolackov K; Łaczmański Ł; Milewicz A
    Gynecol Endocrinol; 2016; 32(3):223-6. PubMed ID: 26486309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Altinkaya SÖ; Nergiz S; Küçük M; Yüksel H
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():168-72. PubMed ID: 24642195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome.
    Demirpence M; Yilmaz Yasar H; Karakoyun I; Girgin EM
    Endokrynol Pol; 2023; 74(2):197-202. PubMed ID: 37155301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
    Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
    Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C; Yoldemir T
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated PAPP-A levels in lean patients with polycystic ovary syndrome.
    Öztürk M; Öktem M; Altinkaya SÖ; Öktem EÖ; Elbeg Ş; Erdem A; Erdem M
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):394-398. PubMed ID: 29880172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evening chronotype is associated with hormonal and metabolic disorders in polycystic ovary syndrome.
    Barrea L; Verde L; Vetrani C; Docimo A; de Alteriis G; Savastano S; Colao A; Muscogiuri G
    J Pineal Res; 2023 Mar; 74(2):e12844. PubMed ID: 36424371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
    Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
    Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
    Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum human Klotho levels and thiol/disulfide homeostasis in women with polycystic ovary syndrome and in healthy women.
    Biyik I; Erten O; Isiklar OO; Ince O; Soysal C; Berikten D; Mammadli S; Oztas E
    Taiwan J Obstet Gynecol; 2021 May; 60(3):487-491. PubMed ID: 33966733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Küçük M; Altınkaya SÖ; Nergiz S; Sezer SD; Yüksel H; Bağlı İ; Yıldız G
    Gynecol Endocrinol; 2014 Jun; 30(6):423-7. PubMed ID: 24628003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.